Leptospira Canicola, C-51, Kb; Leptospira Grippotyphosa, Mal 1540, Kb; Leptospir

15 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

670.0%

Death Rate

Active Ingredients

Leptospira Canicola, C-51, Kb; Leptospira Grippotyphosa, Mal 1540, Kb; Leptospir

Administration Routes

Subcutaneous

Species Affected

Dog 15

Most Affected Breeds

Boxer (German Boxer) 3

Crossbred Canine/dog 2

Poodle - Standard 2

Poodle - Miniature 1

Retriever - Labrador 1

Dachshund - Standard Long-haired 1

Shih Tzu 1

Pug 1

Schnauzer - Miniature 1

Terrier - Bull - American Pit 1

Most Reported Reactions

Other abnormal test result NOS 4

Emesis 3

Anaphylaxis 3

Urticaria 3

Lethargy (see also Central nervous system depression in 'Neurological') 3

Circulatory collapse (see also 'Neurological' and 'Systemic disorders') 2

Lameness 2

Anaphylactoid reaction 2

Injection site swelling 2

Vomiting 2

Fever 2

Seizure NOS 2

Outcome Breakdown

Ongoing

10 (66.7%)

Recovered/Normal

4 (26.7%)

Euthanized

1 (6.7%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.